Roche has solidified its strategic pivot toward the Chinese biotechnology sector by entering into a landmark $400 million partnership with…
Read More

Roche has solidified its strategic pivot toward the Chinese biotechnology sector by entering into a landmark $400 million partnership with…
Read More
Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, evolving from a theoretical "magic bullet" concept into a…
Read More
Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, offering a sophisticated "seek-and-destroy" mechanism that couples the precision…
Read More